Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: A mixed-methods evaluation of the first 18 months

Elaine H. Morrato, Lindsay A. Lennox, Elaina R. Sendro, Anne L. Schuster, Harold A. Pincus, Jennifer Humensky, Gary S. Firestein, Lee M. Nadler, Robert Toto, Steven E. Reis

Research output: Contribution to journalArticlepeer-review

Abstract

Abstract Introduction: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research innovation across the Consortium. Methods: Dissemination of the Accrual to Clinical Trials (ACT) Network, a federated clinical informatics data network for population-based cohort discovery, began January 2018 across the Consortium. Diffusion of innovation theory guided dissemination design and evaluation. Mixed-methods assessed the spread and uptake across the Consortium through July 1, 2019 (n = 48 CTSAs). Methods included prospective time activity tracking (Kaplan-Meier curves), and survey and qualitative interviews. Results: Within 18 months, nearly 80% of CTSAs had joined the data network and two-Thirds of CTSAs achieving technical readiness had initiated launch to local clinical investigators. Over 10,000 ACT Network queries are projected for 2019; and by 2020, nearly all CTSAs will have joined the network. Median time-from-Technical-readiness-To-local-launch was 154 days (interquartile range: 87-225 days]. Quality improvement processes reduced time-To-launch by 35.2% (64 days, p = 0.0036). Lessons learned include: (1) conceptualize dissemination as two-stage adoption demonstrating value for both CTSA hub service providers and clinical investigators; (2) include institutional trial into dissemination strategies so CTSA hubs can refine internal workflows and gather local user feedback endorsement; (3) embrace designing-for-dissemination during technology development; and (4) sustain adaptive dissemination and customer relationship management to keep CTSA hubs and users engaged. Conclusions: Scale-up and spread of the ACT Network provides lessons learned for others disseminating innovation across the CTSA Consortium. The Network is primed for embedded implementation research.

Original languageEnglish (US)
Pages (from-to)515-528
Number of pages14
JournalJournal of Clinical and Translational Science
Volume4
Issue number6
DOIs
StatePublished - 2020

Keywords

  • Clinical and Translational Science Award (CTSA)
  • clinical informatics
  • diffusion of innovation
  • Dissemination
  • scale-up

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: A mixed-methods evaluation of the first 18 months'. Together they form a unique fingerprint.

Cite this